Gary Cai, MSc, RAC has a diverse work experience in regulatory affairs spanning over two decades. Gary has held roles such as VP Regulatory Affairs at INmune Bio Inc., Director Regulatory Affairs at Reistone Biopharma, and Senior Manager Regulatory Affairs at Fresenius Kabi USA. Gary'sexpertise includes positions at prominent companies like Baxter International Inc., EMD Serono, Inc., and Guangzhou Biotechnology Center in China.
Gary Cai holds a Master's Degree in Biological Science from Tsinghua University (1996-1999). Gary also obtained a Certificate in Business Development and Technical Innovation from the Berlin Economics and Management Institute (2004), a Postgraduate Certificate in Regulatory Affairs from Humber College (2007-2008), a Certification in Regulatory Affairs Certified from the Regulatory Affairs Professionals Society (RAPS) (2007-2010), and a Certificate in Business English for Professionals from the University of Toronto (2009-2010).
June, 2022 - present